A New Jersey jury awarded $18 million in compensatory damages Monday to a former user of the painkiller Vioxx, and $2 million to his wife, finding Merck & Co.'s failure to warn of the drug's cardiovascular risks substantially contributed to his heart attack. The damages verdict came 10 days after the jury made a general finding that Merck misrepresented Vioxx's heart risks while marketing it to doctors and suppressed information about the risks. The jury is deliberating whether to award punitive damages.
N.J. Jury Awards $20M to Vioxx User Who Suffered Heart Attack
New Jersey Law Journal
March 13, 2007
This article requires premium access
This article requires premium access to Law.com. Please sign in or subscribe to read the full text.